Wound Management Sells Non-Core Subsidiary; Intends to Focus on CellerateRX and Medical Device Business
In total, over $500,000 in debt was removed from the balance sheet of Wound Management.
Month: February 2012
TONIX Pharmaceuticals Completes $4.3 Million Private Placement Funding
The company received net proceeds of approximately $1.9 million in the offering and converted an additional $1.9 million in previously convertible debentures as part of the offering.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
January/February 2012
The OneMedResearch January/February 2012 Issue discusses the developments of several small companies with intriguing technology in an emerging market. The report contains full financial updates of […]